Tornier N.V. (TRNX)
-NasdaqGS | Prev Close: | 17.02 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 23.22 |
|---|
| Beta: | 1.78 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 14.53 - 23.22 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 159,155 |
|---|
| Market Cap: | 721.94M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.70 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 3 Medical Device Small Caps Trading Below Lowest Target Priceat Seeking Alpha(Thu, May 30)
- This Metric Suggests You're Right to Own Tornier.at Motley Fool(Thu, May 30)
- TORNIER N.V. FinancialsEDGAR Online Financials(Fri, May 17)
- Finding Value in the Medical Products and Device Spaces: An Experienced Portfolio Manager Discusses Investing in Overlooked Health Care AreasWall Street Transcript(Fri, May 17)
- Tornier Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Over-Allotment OptionBusiness Wire(Wed, May 15)
- 5 Healthcare Stock Earnings Snapshotsat Wall St. Cheat Sheet(Sun, May 12)
- TORNIER N.V. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and EEDGAR Online(Fri, May 10)
- Tornier Announces Pricing of Public Offering of Ordinary SharesBusiness Wire(Thu, May 9)
- Tornier's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 8)
- Tornier N.V. Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet(Tue, May 7)
- Tornier Announces Follow-on Offering of Ordinary SharesBusiness Wire(Tue, May 7)
- Tornier Reports First Quarter 2013 ResultsBusiness Wire(Tue, May 7)
- TORNIER N.V. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Tue, May 7)
- Q1 2013 Tornier NV Earnings Release - After Market CloseCCBN(Tue, May 7)
- Tornier to Present at the Bank of America Merrill Lynch 2013 Health Care ConferenceBusiness Wire(Fri, Apr 26)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| TRNX | 0.00% | 721.94M |
| BAX | 0.00% | 38.41B |
| COV | 0.00% | 31.02B |
| CSRT.L | 1.66% | 228.42M |
| BDX | 0.00% | 19.50B |
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.53 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.49 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.14 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | -1.67 |
|---|
Business Summary
Tornier N.V., a medical device company, designs, manufactures, and markets devices for joint replacement and soft tissue repair that enable surgical specialists to enhance patients lives by restoring motion and physical vitality.
View More